"Researchers at the Moores Cancer Center at the University of California, San Diego analyzed data from 864 women with early stage breast cancer who were taking tamoxifen therapy. They found that those who reported having hot flashes were less likely (12.9 percent) to develop recurrent breast cancer than those who did not report hot flashes (21 percent)."

"The researchers also concluded that hot flashes were a stronger predictor of outcome than age, hormone receptor status, or stage of breast cancer at diagnosis. The findings were to be presented Monday at the annual meeting of the American Society of Clinical Oncology, in Chicago."

""This
... read the whole article